TSPAN7 and type 1 diabetes mellitus: McLaughlin et al. [8], using a direct Tspan7 antibody LIPS, detected antibodies in 43% of 94 patients with recent-onset type 1 diabetes aged 12–63 years, and in 1 of 94 non-diabetic controls.